These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 16467191

  • 1. Allosteric modulation of binding properties between units of chemokine receptor homo- and hetero-oligomers.
    Springael JY, Le Minh PN, Urizar E, Costagliola S, Vassart G, Parmentier M.
    Mol Pharmacol; 2006 May; 69(5):1652-61. PubMed ID: 16467191
    [Abstract] [Full Text] [Related]

  • 2. Evidence for negative binding cooperativity within CCR5-CCR2b heterodimers.
    El-Asmar L, Springael JY, Ballet S, Andrieu EU, Vassart G, Parmentier M.
    Mol Pharmacol; 2005 Feb; 67(2):460-9. PubMed ID: 15509716
    [Abstract] [Full Text] [Related]

  • 3. An intracellular allosteric site for a specific class of antagonists of the CC chemokine G protein-coupled receptors CCR4 and CCR5.
    Andrews G, Jones C, Wreggett KA.
    Mol Pharmacol; 2008 Mar; 73(3):855-67. PubMed ID: 18042736
    [Abstract] [Full Text] [Related]

  • 4. Dimerization of chemokine receptors and its functional consequences.
    Springael JY, Urizar E, Parmentier M.
    Cytokine Growth Factor Rev; 2005 Dec; 16(6):611-23. PubMed ID: 15979374
    [Abstract] [Full Text] [Related]

  • 5. Glycoprotein hormone receptors: link between receptor homodimerization and negative cooperativity.
    Urizar E, Montanelli L, Loy T, Bonomi M, Swillens S, Gales C, Bouvier M, Smits G, Vassart G, Costagliola S.
    EMBO J; 2005 Jun 01; 24(11):1954-64. PubMed ID: 15889138
    [Abstract] [Full Text] [Related]

  • 6. Chapter 5. Multiple approaches to the study of chemokine receptor homo- and heterodimerization.
    Rodríguez-Frade J, Muñoz LM, Mellado M.
    Methods Enzymol; 2009 Jun 01; 461():105-22. PubMed ID: 19480916
    [Abstract] [Full Text] [Related]

  • 7. Chemokine receptor dimerization and chemotaxis.
    Rodríguez-Frade JM, Muñoz LM, Holgado BL, Mellado M.
    Methods Mol Biol; 2009 Jun 01; 571():179-98. PubMed ID: 19763967
    [Abstract] [Full Text] [Related]

  • 8. Chapter 12. The use of receptor homology modeling to facilitate the design of selective chemokine receptor antagonists.
    Carter PH, Tebben AJ.
    Methods Enzymol; 2009 Jun 01; 461():249-79. PubMed ID: 19480923
    [Abstract] [Full Text] [Related]

  • 9. Analyzing ligand and small molecule binding activity of solubilized GPCRs using biosensor technology.
    Navratilova I, Dioszegi M, Myszka DG.
    Anal Biochem; 2006 Aug 01; 355(1):132-9. PubMed ID: 16762304
    [Abstract] [Full Text] [Related]

  • 10. Dimerization of chemokine receptors in living cells: key to receptor function and novel targets for therapy.
    Wang J, Norcross M.
    Drug Discov Today; 2008 Jul 01; 13(13-14):625-32. PubMed ID: 18598920
    [Abstract] [Full Text] [Related]

  • 11. Allosteric properties of G protein-coupled receptor oligomers.
    Springael JY, Urizar E, Costagliola S, Vassart G, Parmentier M.
    Pharmacol Ther; 2007 Sep 01; 115(3):410-8. PubMed ID: 17655934
    [Abstract] [Full Text] [Related]

  • 12. Receptor dimerization: a key step in chemokine signaling.
    Mellado M, Vila-Coro AJ, Martínez C, Rodríguez-Frade JM.
    Cell Mol Biol (Noisy-le-grand); 2001 Jun 01; 47(4):575-82. PubMed ID: 11502066
    [Abstract] [Full Text] [Related]

  • 13. Preferential formation of MT1/MT2 melatonin receptor heterodimers with distinct ligand interaction properties compared with MT2 homodimers.
    Ayoub MA, Levoye A, Delagrange P, Jockers R.
    Mol Pharmacol; 2004 Aug 01; 66(2):312-21. PubMed ID: 15266022
    [Abstract] [Full Text] [Related]

  • 14. Chapter 8. Activation mechanisms of chemokine receptors.
    Jensen PC, Rosenkilde MM.
    Methods Enzymol; 2009 Aug 01; 461():171-90. PubMed ID: 19480919
    [Abstract] [Full Text] [Related]

  • 15. Chemokine receptor oligomerization: functional considerations.
    Thelen M, Muñoz LM, Rodríguez-Frade JM, Mellado M.
    Curr Opin Pharmacol; 2010 Feb 01; 10(1):38-43. PubMed ID: 19828377
    [Abstract] [Full Text] [Related]

  • 16. Heterodimerization of CCR2 chemokines and regulation by glycosaminoglycan binding.
    Crown SE, Yu Y, Sweeney MD, Leary JA, Handel TM.
    J Biol Chem; 2006 Sep 01; 281(35):25438-46. PubMed ID: 16803905
    [Abstract] [Full Text] [Related]

  • 17. Analysis of second messenger pathways stimulated by different chemokines acting at the chemokine receptor CCR5.
    Leach K, Charlton SJ, Strange PG.
    Biochem Pharmacol; 2007 Sep 15; 74(6):881-90. PubMed ID: 17645873
    [Abstract] [Full Text] [Related]

  • 18. Glycosaminoglycan disaccharide alters the dimer dissociation constant of the chemokine MIP-1 beta.
    McCornack MA, Boren DM, LiWang PJ.
    Biochemistry; 2004 Aug 10; 43(31):10090-101. PubMed ID: 15287737
    [Abstract] [Full Text] [Related]

  • 19. Allosteric effects of antagonists on signalling by the chemokine receptor CCR5.
    Haworth B, Lin H, Fidock M, Dorr P, Strange PG.
    Biochem Pharmacol; 2007 Sep 15; 74(6):891-7. PubMed ID: 17669370
    [Abstract] [Full Text] [Related]

  • 20. Heterophilic chemokine receptor interactions in chemokine signaling and biology.
    Kramp BK, Sarabi A, Koenen RR, Weber C.
    Exp Cell Res; 2011 Mar 10; 317(5):655-63. PubMed ID: 21146524
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.